Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
LakeShore Biopharma (LSB)
NASDAQ:LSB
LakeShore Biopharma (LSB) Stock Price & Analysis
64 Followers
LSB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.35 - $1.50
Previous Close$0.49
Volume18.43K
Average Volume (3M)59.17K
Market Cap
$92.26M
Enterprise Value$110.93M
Total Cash (Recent Filing)$53.90M
Total Debt (Recent Filing)$72.56M
Price to Earnings (P/E)―
Beta0.30
Next Earnings
Aug 13, 2024EPS Estimate
-$0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding93,058,200
10 Day Avg. Volume49,439
30 Day Avg. Volume59,170
Standard Deviation0.26
R-Squared0.02
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)0.09
Price to Sales (P/S)0.08
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.43
Enterprise Value/Ebitda-172.15
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
LakeShore Biopharma News
PremiumCompany Announcements
LakeShore Biopharma Schedules Crucial EGM
PremiumCompany Announcements
LakeShore Biopharma Announces Executive ReshuffleOwnership Overview
0.00%
Insiders
<0.01% Mutual Funds
1.40% Other Institutional Investors
98.59% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
LSB FAQ
What was LakeShore Biopharma’s price range in the past 12 months?
LakeShore Biopharma lowest stock price was $0.35 and its highest was $1.50 in the past 12 months.
What is LakeShore Biopharma’s market cap?
Currently, no data Available
When is LakeShore Biopharma’s upcoming earnings report date?
LakeShore Biopharma’s upcoming earnings report date is Aug 13, 2024 which is in 22 days.
How were LakeShore Biopharma’s earnings last quarter?
LakeShore Biopharma released its earnings results on Apr 19, 2024. The company reported -$0.08 earnings per share for the quarter, the consensus estimate of -$0.08 by $0.
Is LakeShore Biopharma overvalued?
According to Wall Street analysts LakeShore Biopharma’s price is currently Overvalued.
Does LakeShore Biopharma pay dividends?
LakeShore Biopharma does not currently pay dividends.
What is LakeShore Biopharma’s EPS estimate?
LakeShore Biopharma’s EPS estimate is -$0.09.
How many shares outstanding does LakeShore Biopharma have?
LakeShore Biopharma has 188,327,960 shares outstanding.
What happened to LakeShore Biopharma’s price movement after its last earnings report?
LakeShore Biopharma reported an EPS of -$0.08 in its last earnings report, expectations of -$0.08. Following the earnings report the stock price went down -16.279%.
Which hedge fund is a major shareholder of LakeShore Biopharma?
Among the largest hedge funds holding LakeShore Biopharma’s share is Pinpoint Asset Management Ltd. It holds LakeShore Biopharma’s shares valued at 36K.
---
LakeShore Biopharma Stock Smart Score
Company Description
LakeShore Biopharma
Summit Healthcare Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
---
LSB Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering LSB
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-15.60%
initiated a buy rating 8 months ago
Copying Gregory Aurand's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -15.60% per trade.
---